MedPath

Observational study of therapy with High Intensive Focused Ultrasound (HIFU) at Prostate Cancer

Recruiting
Conditions
C61
Malignant neoplasm of prostate
Registration Number
DRKS00018103
Lead Sponsor
niversitätsklinik für Urologie und Kinderurologie
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Male
Target Recruitment
1000
Inclusion Criteria

1. Patients with prostate cancer in whom a local therapy an improvement of disease situation promises
2. Consent to voluntary participation in the observational study after complete education on nature and purpose of observation, confirmed by signature on enlightenment document

Exclusion Criteria

1. Acute, untreated urinary tract infection
2. Pre-existing urinary or rectal fistula
3. Anal stenosis, the introduction of the HIFU transducer does not allow

Study & Design

Study Type
observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Overall survival of patients<br>There should be a follow-up at yearly intervals. For this purpose, dynamic progress sheets are created, which document a recurrence / progress by means of PSA course and possibly obtained control histology. Any imaging or clinical findings can be recorded.
Secondary Outcome Measures
NameTimeMethod
- Tumor-specific survival<br>- Analysis of the acute and late toxicity of the procedure (effectiveness and effectiveness of HIFU therapy)<br>The follow-up includes standardized questionnaires regarding micturition problems, general quality of life, continence and potency, and finally, concomitant or sequelae, in particular hospitalisation, surgical therapy or others are documented.
© Copyright 2025. All Rights Reserved by MedPath